色又黄又爽18禁免费网站现观看,亚洲无码一,99国产精品国产精品九九,深夜福利久久久久久久久久久

掃碼關(guān)注公眾號           掃碼咨詢技術(shù)支持           掃碼咨詢技術(shù)服務(wù)
  
客服熱線:400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  人才招聘  關(guān)于我們  聯(lián)系我們
產(chǎn)品中心-北京博奧森生物技術(shù)有限公司
Rabbit Anti-DOCK1/BF647 Conjugated antibody (bs-7110R-BF647)
訂購熱線:400-901-9800
訂購郵箱:sales@bioss.com.cn
訂購QQ:  400-901-9800
技術(shù)支持:techsupport@bioss.com.cn
說 明 書: 100ul  
100ul/2980.00元
大包裝/詢價
產(chǎn)品編號 bs-7110R-BF647
英文名稱1 Rabbit Anti-DOCK1/BF647 Conjugated antibody
中文名稱 BF647標(biāo)記的細(xì)胞質(zhì)分裂付出蛋白1抗體
別    名 180 kDa protein downstream of CRK; Ced5; Dedicator of Cytokinesis 1; Dedicator of cytokinesis protein 1; DOCK 1; DOCK-1; DOCK 180; DOCK1; DOCK1_HUMAN; DOCK180.  
規(guī)格價格 100ul/2980元 購買        大包裝/詢價
說 明 書 100ul  
研究領(lǐng)域 腫瘤  細(xì)胞生物  信號轉(zhuǎn)導(dǎo)  細(xì)胞凋亡  細(xì)胞自噬  G蛋白信號  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) (predicted: Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Sheep, )
產(chǎn)品應(yīng)用 IF=1:50-200 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 215kDa
性    狀 Lyophilized or Liquid
濃    度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from human DOCK1
亞    型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
產(chǎn)品介紹 background:
Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Functions as a guanine nucleotide exchange factor (GEF), which activates Rac Rho small GTPases by exchanging bound GDP for free GTP. Its GEF activity may be enhanced by ELMO1.
Tissue specificity: Highly expressed in placenta, lung, kidney, pancreas and ovary. Expressed at intermediate level in thymus, testes and colon.

Function:
Involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Functions as a guanine nucleotide exchange factor (GEF), which activates Rac Rho small GTPases by exchanging bound GDP for free GTP. Its GEF activity may be enhanced by ELMO1.

Subunit:
Interacts with the SH3 domains of CRK and NCK2 via multiple sites. Interacts with nucleotide-free RAC1 via its DHR-2 domain. Interacts with ELMO1, ELMO2 and probably ELMO3 via its SH3 domain. Interacts with RAC1 and BAI1.

Subcellular Location:
Cytoplasm (Probable). Membrane (Probable). Note=Recruited to membranes via its interaction with phosphatidylinositol 3,4,5-trisphosphate (Probable).

Tissue Specificity:
Highly expressed in placenta, lung, kidney, pancreas and ovary. Expressed at intermediate level in thymus, testes and colon.

Similarity:
Belongs to the DOCK family.
Contains 1 DHR-1 domain.
Contains 1 DHR-2 domain.
Contains 1 SH3 domain.

Database links:

Entrez Gene: 1793 Human

Entrez Gene: 330662 Mouse

Entrez Gene: 309081 Rat

Omim: 601403 Human

SwissProt: Q14185 Human

SwissProt: Q8BUR4 Mouse

Unigene: 159195 Human

Unigene: 645702 Human

Unigene: 436572 Mouse



Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

                                    乳腺癌轉(zhuǎn)移的新標(biāo)記物DOCK1
    乳腺癌是一種常常發(fā)生轉(zhuǎn)移的癌癥。將近90%的乳腺癌患者都因為癌癥擴散而死,因此,理解這一危險過程的細(xì)胞和分子基礎(chǔ)機制是十分重要的。
    近日,加拿大蒙特利爾臨床研究所(Institut de recherches cliniques de Montreal, IRCM)的科學(xué)家在乳腺癌研究方面取得了一個重要的發(fā)現(xiàn),他們確定了,一種名為DOCK1的蛋白質(zhì)可以作為潛在的靶標(biāo)用于減少乳腺癌患者的癌轉(zhuǎn)移。相關(guān)研究結(jié)果刊登在了近期出版的《PNAS》上。
    研究人員在乳腺癌治療方面盡管已經(jīng)取得了重要的進(jìn)展,但是對于癌癥擴散的機制卻知之甚少。科學(xué)家正在試圖確定能夠調(diào)節(jié)癌轉(zhuǎn)移過程的蛋白質(zhì),因為它們或許可以作為新的藥物靶標(biāo),并與現(xiàn)有的方法相結(jié)合促進(jìn)治療的效果。
    在這項研究中,2個主要的癌癥亞型——HER-2+型和Basal-like型,很容易轉(zhuǎn)移和復(fù)發(fā),并最終導(dǎo)致患者的低生存率。該調(diào)查以HER-2+(人類表皮生長因子受體2)型為研究對象, 這代表了大約25%的乳腺癌病例。 HER2陽性腫瘤比其它類型的腫瘤更傾向于快速的發(fā)展和擴散。
    研究人員解釋到,通過研究HER2+乳腺癌小鼠模型,確定了DOCK1蛋白質(zhì)是癌轉(zhuǎn)移的一個重要的調(diào)控因子。當(dāng)去除了小鼠中的這一蛋白質(zhì)后,乳腺癌的肺轉(zhuǎn)移大大減少了。此外,研究發(fā)現(xiàn)DOCK1蛋白質(zhì)有助于腫瘤的生長。
    為了證明DOCK1的表達(dá)與乳腺癌預(yù)后之間的關(guān)系,研究人員對包含患者基因信息的幾個數(shù)據(jù)庫進(jìn)行了分析。結(jié)果發(fā)現(xiàn),在HER-2+型或Basal-like型乳腺癌中,高水平的DOCK1與較差的預(yù)后以及疾病的復(fù)發(fā)有關(guān)。
版權(quán)所有 2004-2026 北京博奧森生物技術(shù)有限公司
通過國際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號: 00124Q34771R2M/1100
通過國際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號: CQC24QY10047R0M/1100
京ICP備05066980號-1         京公網(wǎng)安備110107000727號